Univerzitna nemocnica L. Pasteura
- Address
- Trieda SNP 1, 040 11 Košice, Slovakia
Univerzitna nemocnica L. Pasteura - Dermatology Research
Univerzitna nemocnica L. Pasteura is actively engaged in clinical research focused on complex dermatological conditions. The center specializes in investigating novel therapeutic approaches for patients with chronic inflammatory skin diseases, particularly those who have not responded to conventional treatments. Their research emphasizes the evaluation of advanced biologic and targeted therapies in both adult and adolescent populations.
- Hidradenitis Suppurativa treatment research
- Anti-inflammatory therapy evaluation for moderate to severe skin conditions
- Alternative treatment options for anti-TNF therapy non-responders
The center demonstrates particular expertise in managing difficult-to-treat dermatological cases, focusing on patients who are intolerant of or have failed conventional therapies. Their clinical trial portfolio reflects a commitment to advancing treatment options for conditions that significantly impact patient quality of life, with special attention to optimizing outcomes across different age groups including adolescent patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Univerzitna nemocnica L. Pasteura
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Upadacitinib in Moderate to Severe Hidradenitis Suppurativa Post Anti-TNF Therapy Failure | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Oct 2023 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Upadacitinib | 1 | Unknown | 2023-10-26 | 2023-10-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.